Inventor · disambiguated record
Kenneth Granberg
Also filed as: GRANBERG KENNETH · GRANBERG KENNETH LARS
9 granted patents·16 pending applications·22 citations·filing 2005–2024
85Inventor score
Top patents by PatentIndex Score
25 records- 0192US11691978B2Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitorsASTRAZENECA AB·Filed 2021·Granted Jul 4, 2023·2 cites·5 claims
- 0287US10508119B2Pyrazole derivatives useful as 5-lipdxygenase activating protein (FLAP) inhibitorsASTRAZENECA AB·Filed 2018·Granted Dec 17, 2019·5 cites·18 claims
- 0386US11001589B2Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitorsASTRAZENECA AB·Filed 2019·Granted May 11, 2021·4 cites·11 claims
- 0486US10183947B2Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitorsASTRAZENECA AB·Filed 2016·Granted Jan 22, 2019·5 cites·9 claims
- 0583US2024317767A1Pyrazole derivatives useful as 5-lipoxygenase activating protein (flap) inhibitorsASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 0682US12024523B2Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitorsASTRAZENECA AB·Filed 2023·Granted Jul 2, 2024·0 cites·15 claims
- 0774US7678796B2MGluR5 modulators IASTRAZENECA AB·Filed 2007·Granted Mar 16, 2010·3 cites·21 claims
- 0868US8361998B2Compounds and their use as IKACh blockersASTRAZENECA AB·Filed 2011·Granted Jan 29, 2013·2 cites·7 claims
- 0968US2023348363A1Compounds and their useASTRAZENECA AB·Filed 2023·Application pending·0 cites
- 1067US11667602B2Compounds and their useASTRAZENECA AB·Filed 2021·Granted Jun 6, 2023·0 cites·6 claims
- 1159US7419979B2Derivatives of 6-{4-[4-(1H-indole-2-sulphonyl)-piperazin-1-carbonyl-phenyl]}pyradizin-3-oneASTRAZENECA AB·Filed 2005·Granted Sep 2, 2008·1 cites·12 claims
- 1249US2009111811A11,2,4-triazole carboxylic acid derivatives as modulators of mglur5ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 1348US2009111854A11,2,4-triazole aryl n-oxides derivatives as modulators of mglur5ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 1446US2009111857A11,2,4-triazole ether derivatives as modulators of mglur5ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 1544US2013143858A1Compounds and their use as ikach blockersASTRAZENECA AB·Filed 2013·Application pending·0 cites
- 1644US2007259860A1MGluR5 modulators VASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 1743US2008200431A1Heterocyclic Sulfonamide Derivatives as Inhibitors of Factor XaASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 1843US2009111823A1Aminopyridine derivatives as modulators of mglur5ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 1943US2009111824A1Amide linked heteroaromatic derivatives as modulators of mglur5ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 2042US2008214495A1Heterocyclic Sulfonamide Derivatives as Inhibitors of Factor XaASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2141US2009111820A1Fused pyrrolidine 1,2,4-triazole derivatives as modulators of mglur5GRANBERG KENNETH·Filed 2008·Application pending·0 cites
- 2241US2009111822A11,2,3-triazole pyrrolidine derivatives as modulators of mglur5ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 2339US2008221063A1Heterocyclic Sulfonamide Derivatives As Inhibitors Of Factor XaASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2436US2009111825A1Thiophene 1,2,4-triazole derivatives as modulators of mglur5GRANBERG KENNETH·Filed 2008·Application pending·0 cites
- 2529US2010273805A1Sulphide bridged derivatives as modulators of mglur5 733ASTRAZENECA AB·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →